L-Carnitine and Reduced Left Ventricular End-Diastolic Dimension

• Efficacy of L-Carnitine for Dilated Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.

  • 2021-01
  • Meta-Analysis · n = 23
  • BioMed research international 2021(1)
  • • Yayun Weng
    • Shuo Zhang
    • Wei Huang
    • Xianze Xie
    • Zhiyuan Ma
    • Qiaomei Fan

  • PubMed: 33521132
  • DOI: 10.1155/2021/9491615

  6 Insights on

  • Reduced Left Ventricular End-Diastolic Dimension

  • High evidence
  • Clinical

  L-carnitine therapy significantly decreased left ventricular end-diastolic dimension (LVEDD) (MD = -2.53, 95% CI (-3.95, -1.12), P = 0.0005)

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes